|
........................................................................................................................
|
|
Call
for papers
Middle East
Journal of Family Medicine - World
Family Medicine
Print ISSN: 1839-0188 E-ISSN: 1839-0196
The Middle East
Journal of Family Medicine (MEJFM) is
a peer-reviewed journal to meet the needs
of scientists, practitioners, policymakers,
and the patients and communities they
serve in the Middle-East. It is born out
of the growing need for the exchange of
ideas and research results in the region.
It will foster a knowledge base for caring
for individuals, families, societies and
communities. The Mission of the Journal
is to promote family medicine in the Middle
East. The journal publishes original clinical
and educational research of interest to
primary care specialties, practicing clinicians,
residents and others involved in primary
care and community medicine education.
Faculty development and clinical research
and methods are also featured in the journal.
It will include state of the art review
articles based on evidence based medicine
and teaching case reports. Reflections
from editorial members, clinicians and
policy makers will be included as well.
Environmental health and control of environmental
hazards will receive attention, in addition
to the effect of war on health.
The aim of the journal is to provide academically
sound, clinically practical information
for family and general physicians, in
addition to the promotion of the specialty
of family medicine in the Middle East
Region.
The editorial and peer-review processes
of the journal have full editorial autonomy
from both organizational and commercial
pressures. A prominent regional and international
Editorial Board facilitates to direct
the journal to achieve its mission and
foster regional and international participation.
(for details see: http://www.mejfm.com/editorial_board.htm
)
Peer
Review
All papers are subject to Peer Review.
The time this process may take depends
on the topic. The Chief Editor will advise
you re publication date on submission
of your paper.
Article
processing fee and Submission of papers
The article processing charge is US $
1000 for authors from High Income nations.
A thesis or longer papers will be charged
at a higher rate. There may be a discount
for Low Income nations.
Included
in the Article processing fee is 'Plain
English review'.
All papers and enquiries can be submitted
to the Chief Editor on aabyad@cyberia.net.lb,
aabyad
Submission
of the article to the journal can be finalised
once the payment method has been agreed.
Any applicable article processing charge
must be paid prior to publication.
The processing
fee includes the cost of expert English
review.
Impact Factor
It is almost impossible to track all readership
as we are Open Access online and listed
across a variety of databases. The University
of Michigan provides a search facility
for several of our database listings and
this can be found below.
EBSCOhost databases
http://guides.lib.umich.edu/c.php?g=282982&p=3387694
Google Scholar
http://guides.lib.umich.edu/c.php?g=282982&p=3387694
Website/Archives
(all papers since Volume 1, Issue 1 are
free to air on the journal website.)
http://www.mejfm.com/archive.htm
We receive DOI reports from CrossRef outlining
the top 10 DOIs for the quarter and the
top 10 DOIs for the past year. We advise
individual authors if their papers have
achieved this standing.
The above listings do not reflect all
current readership and all current database
listings.
Submission of Manuscripts
All submissions
to MEJFM should include:
1 Covering letter
2 Manuscript including tables and panels
3 Figures
4 Authors statement form (see next section)
5 Conflicts of interest and source of
funding statements (see Code of ethics
section)
6 In-press papers-one copy of each with
acceptance letters
7 Protocols and CONSORT details for randomised
controlled trials (see Code of ethics
section)
8 We encourage disclosure of correspondence
from other journals and reviewers, if
previously submitted, and we might contact
relevant editors of such journals.
References
Vancouver style
o Cite references in the text sequentially
in the Vancouver numbering style, as a
superscripted number after any punctuation
mark. For example:
"…as reported by Saito and colleagues.15"
o Two references are cited separated by
a comma, with no space. Three or more
consecutive references are given as a
range with an en rule. To create an en
rule on a PC: hold down CTRL key and minus
sign on the number pad, or on a Mac:
ALT hyphen
o References in tables, figures, and panels
should be in numerical order according
to where the item is cited in the text
o Here is an example for a journal reference
(note the use of tab, bold, italic, and
the en rule or "long" hyphen):
"…15[tab]Saito N, Ebara S, Ohotsuka
K, Kumeta J, Takaoka K.
Natural history of scoliosis in spastic
cerebral palsy. Lancet 1998; 351: 1687-[en
rule]92."
o Give any subpart to the title of the
article. Journal names are abbreviated
in their standard form as in Index Medicus
o If there are six authors or fewer, give
all six in the form: surname space initials
comma
o If there are seven or more give the
first three in the same way, followed
by et al
o For a book, give any editors and the
publisher, the city of publication, and
year of publication
o For a chapter or section of a book,
also give the authors and title of the
section, and the page numbers
o For online material, please cite the
URL, together with the date you accessed
the website
o Online journal articles can be cited
using the DOI number
o Do not put references in the Summary
Tables,
graphs and Figures
o For best quality reproduction send figures
and graphs as images at 300 dpi.
o Page width is 19cm
o House style is 9pt Calibri
Data
o SI units are required
o Numbers in text and tables should always
be provided if % is shown
o Means should be accompanied by SDs,
and medians by IQR
o Exact p values should be provided, unless
p<0·0001
Drug names
o Recommended international non-proprietary
name (rINN) is required.
Proofs
o The MEJFM employs highly skilled Assistant
Editors, and it is likely that your paper
will be substantially edited after acceptance
to ensure that it is accurate, clear,
and understandable to a wide readership
o All figures and tables may be re-drawn
to 'house style
o You will receive a proof prior to publication.
That proof should be corrected and returned
within 72 hours
Copyright and reuse
o Authors will be asked to sign a transfer
of copyright agreement, which recognises
the common interest that both journal
and author(s) have in the protection of
copyright. We accept that some authors
(eg, government employees in some countries)
are unable to transfer copyright. However,
such policies do not provide anyone other
than The MEJFM journals the right to make
in any form facsimile copies of the version
printed.
Peer review
o Every Article, Case Report, Hypothesis,
Seminar, and Review published has been
peer reviewed. Occasional contributions
(eg, Essays) are accepted without peer
review
MANUSCRIPT PREPARATION
Click
here for pdf of forms to be filled out
Recommendations for the Conduct, Reporting,
Editing, and Publication of Scholarly
Work in Medical Journals
www.icmje.org
All manuscripts
must be accompanied by necessary statements.
Each author must read and sign all statements:
1. Authorship statement on criteria and
responsibility.
2. Financial disclosure statement.
3. Copyright transfer statement (or the
statement of federal employment, if applicable).
4. Human and animal subject protections.
In addition, the corresponding author
must sign:
5. Acknowledgment statement. If necessary,
photocopy this document to distribute
to co-authors for their signatures. Please
send all copies to the Editorial Office
at the time you submit your manuscript.
Author statements
Please insert the relevant text under
the subheadings below. A completed form
must be signed by all authors. Please
note that we cannot accept electronic
signatures; all authors must sign by hand.
Please complete multiple forms if necessary,
and forward the signed copy with your
submission, scan and email to:
Manuscript title:
..................................................................................................................................................................
Corresponding
author:
..................................................................................................................................................................
Article type:
................................................................................................................................................................
Does your manuscript
have a reference number? No [
.....] Yes
[ .....]
If yes, enter number here:
..................................................................................................................................................................
Does your manuscript have a handling editor?
No [ .....]
Yes [ .....]
If yes, enter name here:
.................................................................................................................................................................
Each author must read and sign all statements:
6. Authorship statement on criteria and
responsibility.
7. Financial disclosure statement.
8. Copyright transfer statement (or the
statement of federal employment, if applicable).
9. Human and animal subject protections.
In addition, the corresponding author
must sign:
10. Acknowledgment statement. If necessary,
photocopy this document to distribute
to co-authors for their signatures. Please
send all copies to the Editorial Office
at the time you submit your manuscript.
Manuscript title: .......................................................................................................................................
First author's name: ................................................................................................................................
Authors' contributions
Please insert here the contribution each
author made to the manuscript-e.g. literature
search, figures, study design, data collection,
data analysis, data interpretation, writing
etc. If all authors contributed equally,
please state this. The information provided
here must match the contributors' statement
in the manuscript.
....................................................................................................................................................
....................................................................................................................................................
Role of the
funding source
Please disclose any funding sources and
their role, if any, in the writing of
the manuscript or the decision to submit
it for publication. Examples of involvement
include: data collection, analysis, or
interpretation; trial design; patient
recruitment; or any aspect pertinent to
the study. Please also comment whether
you have been paid to write this article
by a pharmaceutical company or other agency.
If you are the corresponding author, please
indicate if you had full access to all
the data in the study and had final responsibility
for the decision to submit for publication.
The information provided here must match
the role of the funding source statement
in the manuscript.
.................................................................................................................................................................
Conflicts of
interest
Please declare for each author any conflicts
of interest relevant to what you write.
This includes employment, consultancies,
stock ownership, honoraria, paid expert
testimony, patent applications and travel
grants. If there are no conflicts of interest,
please state that there are none. The
information provided here must match the
conflicts of interest statement in the
manuscript.
.................................................................................................................................................................
Patient consent (if applicable) - completion
of this section is mandatory for Case
Reports, Clinical Pictures, and Adverse
Drug Reactions.
Please sign below to confirm that all
necessary consents required by applicable
law from any relevant patient, research
participant, and/or other individual whose
information is included in the article
have been obtained in writing. The signed
consent form(s) should be retained by
the corresponding author and NOT sent
to MEJFM.
.................................................................................................................................................................
Send the following
detail with manuscript:
Why
is this research needed?
What are the
key findings?
How should the
findings be used to influence policy/practice/research/education?
.................................................................................................................................................................
I agree with: the plan to submit to The
MEJFM; the contents of the manuscript;
to being listed as an author; and to the
conflicts of interest statement as summarised.
I have had access to all the data in the
study (for original research articles)
and accept responsibility for its validity.
.................................................................................................................................................................
Title and name (1):
.................................................................................................................................................................
Highest degree:
.................................................................................................................................................................
Signature:
.................................................................................................................................................................
Date:
.................................................................................................................................................................
Title and name (2):
.................................................................................................................................................................
Highest degree:
.................................................................................................................................................................
Signature:
.................................................................................................................................................................
Date:
.................................................................................................................................................................
Title and name (3):
.................................................................................................................................................................
Highest degree:
.................................................................................................................................................................
Signature:
.................................................................................................................................................................
Date:
.................................................................................................................................................................
Title and name (4):
.................................................................................................................................................................
Highest degree:
.................................................................................................................................................................
Signature:
.................................................................................................................................................................
Date:
.................................................................................................................................................................
Title and name (5):
.................................................................................................................................................................
Highest degree:
.................................................................................................................................................................
Signature:
.................................................................................................................................................................
Date:
.................................................................................................................................................................
Title and name (6):
.................................................................................................................................................................
Highest degree:
.................................................................................................................................................................
Signature:
.................................................................................................................................................................
Date:
.................................................................................................................................................................
Title and name
(7):
.................................................................................................................................................................
Highest degree:
.................................................................................................................................................................
Signature:
.................................................................................................................................................................
Date:
.................................................................................................................................................................
Title and name (8):
.................................................................................................................................................................
Highest degree:
.................................................................................................................................................................
Signature:
.................................................................................................................................................................
Date:
.................................................................................................................................................................
Title and name (9):
.................................................................................................................................................................
Highest degree:
.................................................................................................................................................................
Signature:
.................................................................................................................................................................
Date:
.................................................................................................................................................................
Title and name (10):
.................................................................................................................................................................
Highest degree:
.................................................................................................................................................................
Signature:
.................................................................................................................................................................
Date:
.................................................................................................................................................................
Corresponding author declaration
I , the corresponding author of this manuscript,
certify that the contributors' and conflicts
of interest statements included in this
paper are correct and have been approved
by all co-authors
.................................................................................................................................................................
.................................................................................................................................................................
SUBMISSION OF
MANUSCRIPTS
Mail or email manuscripts to:
A. Abyad, MD, MPH, AGSF
Director, Abyad Medical Center & Middle
East Longevity Institute
Coordinator, Ain WaZein Elderly Care Center
Abyad Medical Center
Azmi Street, Abdo Center, 2nd Floor
PO BOX 618 Tripoli, Lebanon
Tel & Fax: 961-6-443684/5/6
Email: aabyad@cyberia.net.lb; aabyad121@gmail.com
........................................................................................................................
|
........................................................................................................................
|
|
|
